Transatlantic rise of health advocacy Patient participation

workshops in denmark , austria have resulted in calls action reinforce patients role in sdm , health advocacy. danish workshop recommended new toolbox of resources patient participation european patients academy on therapeutic innovation (eupati). furthermore danish workshop reported european medicines agency measuring impact of patient involvement , being crucial establishing credibility. , indeed, measurement provided in place cited.

in austria, bibliography inter alia resulted recent event in workshop series continuing through 2019 entitled toward shared culture of health: enriching , charting patient-clinician relationship held 10–16 march, 2017.

in netherlands, there debate relative value of patient participation versus decisions without explicitly empowering patients. bovenkamp 1 of vocal opponents challenging patients stakeholders in clinical guideline development. adonis more positive in shorter paper. caron-flinterman goes more detail in dissertation.

in norway, nilsen et al. critical of patients role in health policy , clinical guideline development in cochrane intervention review. 2 other norwegian researchers, though, in unison workshop findings above, expand list of areas patients views matter: central arena patient participation meeting between patient , health professional, other important areas of involvement include decisions @ system , policy levels .

in united states there several trends emerging potential international implications: health 2.0, artificial intelligence in healthcare (ai), role of entrepreneurs, value of patient participation in precision medicine , mobile health or mhealth, dealt in greater detail below.